Just last week, Lake Oswego, Oregon-based Biotronik announced that two of its new products, the SentusProMRI and its MultiPole Pacing technology, were approved by the U.S. Food and Drug Administration (FDA). This week at the annual Heart Rhythm Society conference in Chicago, the company showed off the new devices.

While atrial fibrillation (AFib) and heart disease continue to plague patients globally, some cardiologists have made it their mission to help underserved communities in foreign countries as they look for ways to use their specialties for good.

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), to help guide therapy.

To enhance its pediatric cardiac services, Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, has named two new cardiac specialists to head its heart institute.

Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation Impella CP heart pump at the Annual meeting of the Society for Cardiovascular and Angiography Interventions (SCAI 2017) in New Orleans, LA.

Abiomed has debuted the third generation of its Impella CP heart pump, a device designed to unload the heart and let it naturally recover. 

Biotronik’s Sentus ProMRI, a thin quadripolar left ventricular lead, has been approved by the U.S. Food and Drug Administration (FDA), the company announced today.

Cardiologist Cindy Grimes, MD, who helped pioneer the use of percutaneous coronary intervention (PCI) for heart attacks, has been named the chair of cardiology at the Hofstra Northwell School of Medicine, according to a press release.